Raffles Medical Group Ltd. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2018. For the quarter, the company reported revenue of SGD 121,039,000 against SGD 119,585,000 a year ago. Profit from operating activities was SGD 19,216,000 against SGD 18,390,000 a year ago. Profit before tax was SGD 19,088,000 against SGD 18,574,000 a year ago. Profit attributable to owners of the company was SGD 16,410,000 against SGD 16,397,000 a year ago. Basic earnings per share were 0.91 cents against 0.93 cents a year ago. Diluted earnings per share were 0.91 cents against 0.92 cents a year ago.

For the nine months, the company reported revenue of SGD 361,430,000 against SGD 354,588,000 a year ago. Profit from operating activities was SGD 58,378,000 against SGD 56,055,000 a year ago. Profit before tax was SGD 58,226,000 against SGD 56,639,000 a year ago. Profit attributable to owners of the company was SGD 49,113,000 against SGD 48,705,000 a year ago. Basic earnings per share were 2.76 cents against 2.77 cents a year ago. Diluted earnings per share were 2.75 cents against 2.76 cents a year ago. Group net asset value per ordinary share was 42.51 cents against 41.45 cents a year ago. On company basis net asset value per ordinary share was 36.05 cents against 34.36 cents a year ago. Net cash from operating activities was SGD 31,711,000 against SGD 24,486,000 a year ago. Acquisition of intangible assets was SGD 337,000. Purchase of property, plant and equipment was SGD 4,510,000 against SGD 4,316,000 a year ago.

Based on the current economic conditions and barring unforeseen circumstances, the Directors expect the Group to grow and remain profitable in 2018.